ALXN (Alexion Pharmaceuticals, Inc.)

Price: $150.1
Dividend Ratio:0%
http://www.alexion.com
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) http://www.portola.com
Updated: March 08, 2021 12:11 AM